AUS
NZ
UK
CA
USA
IND
Healthcare
Is Aroa Biosurgery Entering a New Era of Growth?
May 29, 2026 04:35 PM AEST| By SamAroa Biosurgery’s latest financial performance highlights profitability, healthcare market expansion, and evolving valuation discussions as investors assess the company’s long-term growth outlook.
Healthcare Stocks Enter a Catalyst-Rich Phase as Sector Eyes Fresh Momentum
May 29, 2026 04:29 PM AEST| By SamAustralian healthcare stocks are entering a catalyst-heavy phase with regulatory progress, clinical developments, commercial expansion, and innovation-led growth initiatives supporting sector-wide attention.
Why ASX Healthcare Names Keep Drawing Attention
May 29, 2026 02:21 PM AEST| By SamHealthcare companies remain active across radiopharmaceuticals, wound-care devices and diagnostic programs as commercial traction shapes sector discussion.
What Makes These ASX Healthcare Service Names Stand Out?
May 29, 2026 02:15 PM AEST| By SamSonic Healthcare, Healius and Integral Diagnostics operate across pathology, diagnostic services and imaging networks within Australia’s healthcare sector.
ASX 200 Healthcare Leaders Anchoring Market Strength
May 29, 2026 02:10 PM AEST| By SamASX healthcare stocks CSL, COH, and RMD showcase global medical innovation, device leadership, and therapy development across diverse healthcare segments.
Why Alcidion’s Latest Share Move Is Drawing Attention
May 29, 2026 11:00 AM AEST| By SamAlcidion continues drawing attention as digital healthcare expansion and new ASX share quotation activity remain in focus.
Why This ASX Healthcare Share Is Suddenly Back in the Spotlight
May 29, 2026 09:52 AM AEST| By SamImugene remains firmly on healthcare watchlists as oncology trial milestones and treatment development continue progressing.
Seaweed Trade Momentum Builds for BPH Global
May 28, 2026 08:12 PM AEST| By SamBPH Global strengthens its seaweed trading operations in Indonesia as favourable seasonal conditions support supply growth, stable demand and expanding opportunities across marine-based industries.
Australian Medical Shares Maintain Market Visibility
May 28, 2026 08:05 PM AEST| By SamHealthcare Stocks across Australian markets continue drawing attention as biotech companies, healthcare device manufacturers, and medical service providers expand operational activity.
Are ASX 200 Healthcare Stocks Back in Focus?
May 28, 2026 08:02 PM AEST| By SamASX Healthcare Stocks remain linked with biotechnology, medical devices, diagnostics, hospital services, and XHJ-led sector activity across Australia’s market.
Why Are Healthcare Stocks (ASX:COH, ASX:RMD) Holding ASX 200 Strong?
May 28, 2026 07:55 PM AEST| By SamHealthcare Stocks on the ASX highlight defensive sector characteristics, with stable demand, essential services, and key companies shaping market activity across global healthcare industries.
Nyrada Gains Market Attention Amid Growth Momentum
May 28, 2026 04:18 PM AEST| By SamNyrada is drawing investor attention through revenue expansion, innovation initiatives, and business growth momentum despite ongoing focus on cash management and future funding strategy.
Imugene Advances Cancer Therapy Research With New Clinical Milestone
May 28, 2026 03:14 PM AEST| By SamImugene advances its azer-cel clinical study with expanded patient enrolment and combination therapy research focused on blood cancer treatment innovation and broader global clinical development.
Recce Pharmaceuticals Gains Momentum Amid Strong Insider Confidence
May 28, 2026 03:11 PM AEST| By SamRecce Pharmaceuticals gains investor attention following strong insider participation and improving market sentiment, reinforcing confidence around the biotechnology company’s long-term growth journey.
Why CSL Shares Are Drawing Fresh Attention on the ASX
May 28, 2026 02:50 PM AEST| By SamCSL shares remain in focus as healthcare demand, global expansion, and interest in ASX dividend stocks continue to support attention toward the biotechnology giant.
Why CSL’s Sharp Slide Is Putting the Healthcare Giant Back in Focus
May 28, 2026 02:00 PM AEST| By SamCSL shares remain closely watched as the biotechnology giant navigates valuation pressure and long-term healthcare growth trends.
Why ASX 200 Healthcare Stock Telix Pharmaceuticals Is Drawing Fresh Market Attention
May 28, 2026 10:02 AM AEST| By SamTelix Pharmaceuticals Ltd (ASX:TLX) gained attention after advancing its glioblastoma therapy program, with investors closely watching radiopharmaceutical growth opportunities, clinical trial progress, and the company’s expanding neuro-oncology strat...
Recce Pharmaceuticals Expands Reach Across MENA Healthcare Markets
May 27, 2026 07:31 PM AEST| By SamRecce Pharmaceuticals expands into the MENA healthcare market with a long-term licensing arrangement for diabetic foot infection treatment, strengthening focus on pharmaceutical innovation and regional healthcare accessibility.
What Sets Top ASX Healthcare Stocks Apart in 2026
May 27, 2026 06:15 PM AEST| By SamASX healthcare stocks require analysis of product technology, research investment, geographic reach, competitive strength, reimbursement settings, regulation and capital allocation across global healthcare markets.
Why ASX Healthcare Shares Keep Testing Market Nerves
May 27, 2026 05:49 PM AEST| By SamASX healthcare shares face risks from regulation, currency swings, operational costs, and competition, with CSL volatility highlighting why diversification and sector awareness remain important across Australian healthcare portfolios.
Advertise your brand on Kalkine Media